The clinical profile of patients with indeterminate Xpert rifampin resistance results in a single tertiary level institution.

IF 1.8 4区医学 Q3 INFECTIOUS DISEASES

Diagnostic microbiology and infectious disease Pub Date : 2025-12-01 Epub Date: 2025-07-26 DOI:10.1016/j.diagmicrobio.2025.117008

Bettina Gabrielle Tenorio, Danielle Josefa Uayan, Kriselle Felicia Lumunsad, Andrea Estuart, Jose Carlos Ruben Javier, Cybele Lara Abad

引用次数: 0

Abstract

The significance of indeterminate rifampin resistance (RR) Xpert results remains unclear. Databases from 2016 to 2023 were reviewed, leading to inclusion of 31 cases. Majority were male, newly-diagnosed, symptomatic, and had comorbidities. On culture, ten were rifampin-susceptible, and two rifampin-resistant. Indeterminate results cannot be interpreted, and final TB cultures should be followed-up.

查看原文本刊更多论文

不确定的Xpert利福平耐药患者的临床概况导致单一三级机构。

不确定的利福平耐药（RR） Xpert结果的意义尚不清楚。我们回顾了2016年至2023年的数据库，共纳入31例病例。大多数是男性，新诊断，有症状，并有合并症。培养中，10人对利福平敏感，2人对利福平耐药。不确定的结果无法解释，最终的结核培养应予以随访。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Diagnostic microbiology and infectious disease 医学-传染病学

CiteScore

5.30

自引率

3.40%

发文量

149

审稿时长

56 days

期刊介绍： Diagnostic Microbiology and Infectious Disease keeps you informed of the latest developments in clinical microbiology and the diagnosis and treatment of infectious diseases. Packed with rigorously peer-reviewed articles and studies in bacteriology, immunology, immunoserology, infectious diseases, mycology, parasitology, and virology, the journal examines new procedures, unusual cases, controversial issues, and important new literature. Diagnostic Microbiology and Infectious Disease distinguished independent editorial board, consisting of experts from many medical specialties, ensures you extensive and authoritative coverage.